Applicant, as named in the Orange Book

Rvl Pharms

Next listed expiry: Upneeq on 16 Dec 2039. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Upneeq oxymetazoline hydrochloride	oxymetazoline hydrochloride	212520	16 Dec 2039	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.